AMICUS THERAPEUTICS, INC. Payment for Contingent Consideration Liability, Operating Activities
AMICUS THERAPEUTICS, INC. reported Payment for Contingent Consideration Liability, Operating Activities of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-20.
Financial Statements › Cash Flow › Operating Activities
us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities · last filed 2026-02-20
- AMICUS THERAPEUTICS, INC. payment for contingent consideration liability, operating activities for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- AMICUS THERAPEUTICS, INC. payment for contingent consideration liability, operating activities for the quarter ending 2024-09-30 was $0.00.
- AMICUS THERAPEUTICS, INC. payment for contingent consideration liability, operating activities for the quarter ending 2023-12-31 was $13.41M.
- AMICUS THERAPEUTICS, INC. payment for contingent consideration liability, operating activities for the quarter ending 2023-09-30 was $0.00.
- AMICUS THERAPEUTICS, INC. payment for contingent consideration liability, operating activities for fiscal 2025 was $0.00.
- AMICUS THERAPEUTICS, INC. payment for contingent consideration liability, operating activities for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- AMICUS THERAPEUTICS, INC. payment for contingent consideration liability, operating activities for fiscal 2023 was $21.35M.
- AMICUS THERAPEUTICS, INC. payment for contingent consideration liability, operating activities for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
| Period end | Payment for Contingent Consideration Liability, Operating Activities 3 month | Payment for Contingent Consideration Liability, Operating Activities 6 month | Payment for Contingent Consideration Liability, Operating Activities 9 month | Payment for Contingent Consideration Liability, Operating Activities 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-20 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $0.00 derived: sum of 2 quarters · filed 2026-02-20 | $0.00 10-K · filed 2026-02-20 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $0.00 10-Q · filed 2024-11-06 | ||
| 2024-06-30 | $0.00 10-Q · filed 2024-08-08 | |||
| 2023-12-31 | $13.41M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $13.41M derived: sum of 2 quarters · filed 2026-02-20 | $21.35M 10-K · filed 2026-02-20 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $7.94M 10-Q · filed 2024-11-06 | ||
| 2023-06-30 | $7.94M 10-Q · filed 2024-08-08 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19 | $0.00 derived: sum of 2 quarters · filed 2025-02-19 | $0.00 10-K · filed 2025-02-19 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $0.00 10-Q · filed 2023-11-08 | ||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-08 | |||
| 2021-12-31 | $10.35M 10-K · filed 2024-02-28 | |||
| 2020-12-31 | $0.00 10-K · filed 2023-03-01 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-02-24 |